DesigneRx Pharmaceuticals

DesigneRx Pharmaceuticals (DRX) is a company that specializes in therapeutic protein drug manufacturing. It is engaged in the development of pegylated arginine deiminase (ADI-PEG 20), an anticancer enzyme that can be used to treat hepatocellular carcinoma, non-small cell lung cancer, melanoma, mesothelioma, pancreatic cancer, prostate cancer, leukemia, lymphoma, and breast cancer.
0
TypeSubsidiary
HQVacaville, US
Founded2002
Websitedrxpharma.com
Cybersecurity ratingBMore
DesigneRx Pharmaceuticals was founded in 2002 and is headquartered in Vacaville, US

Viewing summary data as a guest

Sign up for free to see all data

DesigneRx Pharmaceuticals Office Locations

DesigneRx Pharmaceuticals has an office in Vacaville
Vacaville, US (HQ)
4941 Allison Pkwy suite b
Show all (1)

DesigneRx Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

2002

DesigneRx Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

B

85/100

SecurityScorecard logo

DesigneRx Pharmaceuticals Online and Social Media Presence

Embed Graph

DesigneRx Pharmaceuticals Frequently Asked Questions

  • When was DesigneRx Pharmaceuticals founded?

    DesigneRx Pharmaceuticals was founded in 2002.

  • Who are DesigneRx Pharmaceuticals competitors?

    Competitors of DesigneRx Pharmaceuticals include Mirati Therapeutics, Merrimack Pharmaceuticals and Genocea Biosciences.

  • Where is DesigneRx Pharmaceuticals headquarters?

    DesigneRx Pharmaceuticals headquarters is located at 4941 Allison Pkwy suite b, Vacaville.

  • Where are DesigneRx Pharmaceuticals offices?

    DesigneRx Pharmaceuticals has an office in Vacaville.

  • How many offices does DesigneRx Pharmaceuticals have?

    DesigneRx Pharmaceuticals has 1 office.